Open source Jul 21, 2026 Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Open source 1 Min Read Defense tech is flooded with money, but who’s built to last? By Editorial Team June 3, 2026 Read Article
Open source 4 Min Read OpenAI alums have been quietly investing from a new, potentially $100M fund By Editorial Team April 7, 2026 Read Article